Comparison of outcomes in patients with versus without diabetes mellitus after revascularization with everolimus- and sirolimus-eluting stents (from the SORT OUT IV trial).
Explore this paper's citation graph
Summary
Patients with diabetes have higher MACE rates than nondiabetics, and no significant differences in safety or efficacy outcomes after EES or SES implantation were present in nondiabetic or diabetic patients.
- Type
- article
- Published
- 2012-12-01
- Cited by
- 57
- References
- 21
- OpenAlex
- https://openalex.org/W22959714
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:8655762
Keywords
Philosophy
References
- The Danish National Hospital Register. A valuable source of data for modern health sciences.
- Biodegradable polymer versus permanent polymer drug-eluting stents and everolimus- versus sirolimus-eluting stents in patients with coronary artery disease: 3-year outcomes from a randomized clinical trial.
- Vascular effects of sirolimus-eluting versus bare-metal stents in diabetic patients: three-dimensional ultrasound results of the Diabetes and Sirolimus-Eluting Stent (DIABETES) Trial.
- Outcomes in diabetic and nondiabetic patients treated with everolimus- or paclitaxel-eluting stents: results from the SPIRIT IV clinical trial (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System).
- When an Entire Country Is a Cohort
- Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients.
- Estimation of failure probabilities in the presence of competing risks: new representations of old estimators.
- Modeling and variable selection in epidemiologic analysis.
- A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.
- Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease.
- Rationale and Design of a Randomized Clinical Comparison of Everolimus-Eluting (Xience V/Promus) and Sirolimus-Eluting (Cypher Select+) Coronary Stents in Unselected Patients with Coronary Heart Disease
- Comparison of the sirolimus-eluting versus paclitaxel-eluting coronary stent in patients with diabetes mellitus: the diabetes and drug-eluting stent (DiabeDES) randomized angiography trial.
- Neointimal hyperplasia after sirolimus-eluting and paclitaxel-eluting stent implantation in diabetic patients: the Randomized Diabetes and Drug-Eluting Stent (DiabeDES) Intravascular Ultrasound Trial.
- Outcome of sirolimus-eluting versus zotarolimus-eluting coronary stent implantation in patients with and without diabetes mellitus (a SORT OUT III Substudy).
- Two-year clinical outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents in diabetic patients.
- Randomized Comparison of Everolimus-Eluting Stent Versus Sirolimus-Eluting Stent Implantation for De Novo Coronary Artery Disease in Patients With Diabetes Mellitus (ESSENCE-DIABETES): Results From the ESSENCE-DIABETES Trial
- Stent thrombosis, myocardial infarction, and death after drug-eluting and bare-metal stent coronary interventions.
- Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions
- The Danish registers of causes of death.
- Late lumen loss and intima hyperplasia after sirolimus-eluting and zotarolimus-eluting stent implantation in diabetic patients: the diabetes and drug-eluting stent (DiabeDES III) angiography and intravascular ultrasound trial.
Cited by
- Second- versus first-generation drug-eluting stents for diabetic patients: a meta-analysis
- Impact of diabetes on the benefits from everolimus-eluting stent as compared to first-generation drug-eluting stent in patients with ST elevation myocardial infarction
- Desfechos clínicos tardios de pacientes diabéticos tratados com stents farmacológicos eluidores de sirolimus ou everolimus: uma análise do registro DESIRE
- Clinical Outcomes According to Diabetic Status in Patients Treated With Biodegradable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents: Prespecified Subgroup Analysis of the BIOSCIENCE Trial
- A 10‐month angiographic and 4‐year clinical outcome of everolimus‐eluting versus sirolimus‐eluting coronary stents in patients with diabetes mellitus (the diabedES IV randomized angiography trial)
- Clinical Outcome Comparison of Everolimus- and Biolimus-eluting Stents in Patients with Acute Myocardial Infarction
- New-generation drug-eluting stents: focus on Xience V® everolimus-eluting stent and Resolute® zotarolimus-eluting stent.
- Biolimus-Eluting StenT For de-novo coRonary artery dIsease in patiENts with Diabetes mellituS: the BESTFRIENDS multicentre registry
- Evolution of coronary stents in patients with diabetes: are clinical outcomes still improving?
- Long-term outcome of sirolimus-eluting and zotarolimus-eluting coronary stent implantation in patients with and without diabetes mellitus (a Danish organization for randomized trials on clinical outcome III substudy).
- Everolimus-eluting versus sirolimus-eluting coronary stents in patients with and without diabetes mellitus.
- The Resolute™ Integrity Zotarolimus-Eluting Stent in Coronary Artery Disease: A Review
- Diabetes and everolimus-eluting stents: what we know and what is still missing. Insights from subanalysis of the SORT OUT IV trial
- Histone Demethylase JMJD2A Inhibition Attenuates Neointimal Hyperplasia in the Carotid Arteries of Balloon-Injured Diabetic Rats via Transcriptional Silencing: Inflammatory Gene Expression in Vascular Smooth Muscle Cells
- Drug-eluting stent outcomes in diabetes
- Revascularization strategies in patients with Type 2 diabetes mellitus
- Gender‐related differences in elderly patients with myocardial infarction in a European Centre
- A Multicenter Registry on the Risk-Benefit Balance of Avantgarde Carbofilm- Coated Stent in Real-World Patients at High Risk for Early Discontinuation of Dual Antiplatelet Therapy Undergoing Percutaneous Coronary Intervention: Focus on Diabetic Status
- Late clinical outcomes of diabetic patients treated with sirolimus or everolimus drug-eluting stents: an analysis of the DESIRE registry
- Impact of Modifiable Cardiovascular Risk Factors on Mortality After Percutaneous Coronary Intervention
Related papers
No related papers recorded.